Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

JAMA Cardiology

2025-08-30

(Press-News.org) About The Study: Randomization systolic blood pressure (SBP) was associated with the survival benefit of microaxial flow pump treatment, with the most hypotensive patients deriving the largest survival benefit. Early SBP may help identify patients most likely to gain a net benefit from microaxial flow pump treatment. Findings are hypothesis generating.

Corresponding Author: To contact the corresponding author, Astrid Duus Mikkelsen, MD, email astrid.duus.mikkelsen@reigonh.dk.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2025.3337?guestAccessKey=7d97951f-1028-4d1f-9e0b-68f756fb4d9e&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=083025

END

ELSE PRESS RELEASES FROM THIS DATE:

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

2025-08-30

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with preserved heart function. Beta blockers have been the standard treatment for these patients for 40 years. This is a breakthrough discovery from the “REBOOT Trial” with senior investigator Valentin Fuster, MD, PhD, President of Mount Sinai Fuster Heart Hospital and General Director of Spain’s Centro Nacional de Investigaciones Cardiovasculares ...

High Mountain Asia’s shrinking glaciers linked to monsoon changes

2025-08-29

Glaciers across High Mountain Asia are losing more than 22 gigatons of ice per year—the equivalent to nearly 9 million Olympic swimming pools, according to research from the University of Utah and Virginia Tech. The impact of a warming climate on glacial loss is undisputed—this new study provides the first evidence that seasonal shifts in rainfall and snowfall patterns, particularly of the South Asian monsoons, are also exacerbating glacier melting across the region. “These findings highlight that glaciers dominated by the South Asian monsoons, such as the Central Himalaya, ...

All DRII-ed up: How do plants recover after drought?

2025-08-29

LA JOLLA (August 29, 2025)—A plant’s number one priority is to grow—a feat that demands sunlight, nutrients, and water. If just one of these three inputs is missing, like water in a drought, growth halts. You might then think that at the end of that drought, the plant would jump right back into growing. Instead, its priorities shift. Salk plant biologists used advanced single-cell and spatial transcriptomic techniques to look closely at how a small, flowering plant called Arabidopsis thaliana recovers after drought. They discovered that immunity became the plant’s number one priority during this ...

Research on stigma says to just ‘shake it off’

2025-08-29

The stereotypical employee may be at a desk in front of a computer screen working a nine-to-five, but for many employees, the work day is filled with manual labor, hazardous environments and late-night shifts. Your local garbage collector, for example, is someone with a job that society might consider “dirty,” both literally and socially. Scott Dust, PhD, professor in the management department at the University of Cincinnati Carl H. Lindner College of Business, worked with doctoral candidates Sodiq Babatunde and Ben Fagan to analyze the impact of stress and ...

Scientists track lightning “pollution” in real time using NASA satellite

2025-08-29

Picture this: You’re stuck in traffic on a summer afternoon, checking the weather app on your phone as dark storm clouds roll in. You might think about power outages or possible flooding, but you probably don’t think about how every lightning bolt that flashes across the sky also emits a gas, nitrogen oxide (NO), that is also emitted in the exhaust from your car’s engine. Yet, that’s exactly what occurs during a thunderstorm. For the first time, scientists from the University of Maryland were able to detect lightning and its impact on air quality using high-frequency ...

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

2025-08-29

Hormonal birth control is a fact of life for millions of women. In the U.S. alone, more than 60 million women of reproductive age have used contraceptives according to the Centers for Disease Control and Prevention, most often to prevent pregnancy but also to manage conditions such as endometriosis, polycystic ovary syndrome and irregular cycles. And as many women will attest, these drugs can affect more than the body. Mood changes, weight fluctuations and emotional ups and downs are common stories women ...

Hot days make for icy weather, Philippine study finds

2025-08-29

The Philippines, like other tropical countries, is known more for its balmy climate than for hailstorms. But a new Philippine study—the first of its kind—has found that the country’s hottest days are, in fact, more likely to produce hail. Hailstorms are so few and far between in the Philippines that, even in an age of pervasive social media updates, they are still met with amazement and astonishment. “Most people are surprised when hail happens because it is relatively rare in the Philippines,” ...

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

2025-08-29

The European Society of Cardiology (ESC) has selected Roxana Mehran, MD, Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute at the Icahn School of Medicine at Mount Sinai, as a winner of the organization’s top honor. Dr. Mehran was presented with the “ESC Gold Medal” during a special ceremony at the ESC Congress in Madrid on Friday, August 29. The ESC Gold Medal recognizes exceptional scientists for their contributions to cardiovascular ...

World's first clinical trial showing lubiprostone aids kidney function

2025-08-29

Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to avoid kidney failure and stay alive. Despite the severity of the condition, there are currently no drugs available that improve kidney function. A research group led by Tohoku University Graduate School of Medicine’s Professor Takaaki Abe has found a remarkable solution to treat patients with CKD by co-opting a drug typically used for constipation. This is the first time that this drug (lubiprostone) was shown to prevent the decline of renal function in patients with ...

Capturing language change through the genes

2025-08-29

Throughout human history, there have been many instances where two populations came into contact – especially in the past few thousand years because of large-scale migrations as a consequence of conquests, colonialization, and, more recently, globalization. During these encounters, not only did populations exchange genetic material, but also cultural elements. When populations interact, they may borrow technologies, beliefs, practices, and also, crucially, aspects of language. With this, sounds, words or grammatical patterns can be exchanged ...

LAST 30 PRESS RELEASES:

Heatwaves linked to rise in sleep apnoea cases in Europe

Down‑top strategy engineered large‑scale fluorographene/PBO nanofibers composite papers with excellent wave‑transparent performance and thermal conductivity

World Health Organization’s priorities shaped by its reliance on grants from donor organisations such as the Gates Foundation

Dr. Loren Miller presents oral late breaker at IDWeek 2025 of a first-of-its-kind clinical trial that shows efficacy of bacteriophage therapy for Staphylococcus aureus bacteremia